This finding elucidates a new molecular mechanism underlying the crosstalk between EV secretion and cell metabolic switch to promote tumor progression, in which let-7a/SNAP23 may provide novel approaches for CRC therapy. Here, SNAP23 is linked to colorectal carcinoma.